Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8598191 Controlled release compositions of gamma-hydroxybutyrate

Patent 8598191 was granted and assigned to Supernus Pharmaceuticals, Inc. on December, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

Supernus Pharmaceuticals, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8598191

Date of Patent

December 3, 2013

Patent Application Number

13476369

Date Filed

May 21, 2012

Patent Citations Received

‌

US Patent 12128021 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

‌

US Patent 12115143 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

‌

US Patent 12115144 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

‌

US Patent 12115145 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

‌

US Patent 11766418 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

‌

US Patent 11779557 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

‌

US Patent 11839597 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

‌

US Patent 11986451 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

...

Patent Primary Examiner

‌

Susan Tran

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8598191 Controlled release compositions of gamma-hydroxybutyrate

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API